Quantum-Si Incorporated (NASDAQ:QSI – Get Free Report) Director Charles Kummeth purchased 500,000 shares of Quantum-Si stock in a transaction dated Thursday, March 5th. The shares were purchased at an average cost of $0.92 per share, for a total transaction of $460,000.00. Following the completion of the transaction, the director owned 855,000 shares of the company’s stock, valued at approximately $786,600. This represents a 140.85% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Quantum-Si Stock Down 3.9%
Shares of QSI stock opened at $0.87 on Monday. Quantum-Si Incorporated has a 12-month low of $0.84 and a 12-month high of $3.10. The firm has a fifty day moving average of $1.10 and a 200-day moving average of $1.37. The firm has a market capitalization of $188.36 million, a price-to-earnings ratio of -1.68 and a beta of 3.00.
Quantum-Si (NASDAQ:QSI – Get Free Report) last released its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.14) by $0.06. The business had revenue of $0.45 million for the quarter, compared to analysts’ expectations of $0.76 million. Quantum-Si had a negative return on equity of 43.90% and a negative net margin of 4,160.06%. Research analysts expect that Quantum-Si Incorporated will post -0.65 earnings per share for the current year.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
QSI has been the subject of several research analyst reports. Canaccord Genuity Group reduced their target price on Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research note on Wednesday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Quantum-Si in a report on Monday, December 29th. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Quantum-Si presently has an average rating of “Hold” and an average target price of $3.25.
Check Out Our Latest Stock Analysis on Quantum-Si
About Quantum-Si
Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.
Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.
Read More
- Five stocks we like better than Quantum-Si
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.
